logo
Plus   Neg
Share
Email

Luminex Gets Emergency Use Authorization For Expanded Version Of NxTAG Respiratory Pathogen Panel

Luminex Corp. (LMNX) said it has received Emergency Use Authorization from the FDA for a new expanded version of NxTAG Respiratory Pathogen Panel that includes the SARS-CoV-2 virus for high-throughput respiratory testing. Luminex Corp. said the NxTAG RPP + SARS-CoV-2 Assay is expected to detect new variants of the coronavirus.

NxTAG RPP provides allows clinical labs to run up to 96 samples at a time. The test runs on Luminex's MAGPIX System.

"Given the emergence of new respiratory pathogens and new variants of these pathogens, it will be increasingly challenging to identify and distinguish the presence and co-existence of SARS-CoV-2, influenza, and other common respiratory pathogens. Our NxTAG RPP + SARS-CoV-2 test delivers an ideal solution for this challenge," said Nachum Shamir, CEO of Luminex.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
ViacomCBS Inc. announced plans to combine CBS News and the CBS Television Stations. The journalistic and business operations of both will be combined into one divisional and leadership structure. Neeraj Khemlani and Wendy McMahon were appointed as presidents and co-heads of the newly formed division, effective early next month. Retail major Target Corp. is recalling about 44,350 units of Cat & Jack Baby Heart Ears Rompers, citing choking risks to children, the U.S. Consumer Product Safety Commission said in a statement. The recall involves rompers sold in various sizes from newborn to 24 months. The rompers were manufactured in Vietnam, and sold at Target stores across the United States and online. Alcoa Corp. (AA), the largest producer of aluminum in the US, Thursday reported a first-quarter profit that more than doubled from a year ago, driven by increased shipments and prices. Both adjusted earnings and revenues for the quarter trumped Wall Street analysts' estimates. Pittsburgh-based Alcoa...
Follow RTT